Stay updated with breaking news from Entrypoint Capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Oppenheimer cut shares of Generac (NYSE:GNRC – Free Report) from an outperform rating to a market perform rating in a report issued on Wednesday morning, Marketbeat Ratings reports. A number of other equities research analysts also recently issued reports on the stock. Robert W. Baird upped their price objective on shares of Generac from $112.00 […]
Cogent Communications Holdings, Inc. (NASDAQ:CCOI – Get Free Report) Director Sheryl Lynn Kennedy sold 1,640 shares of the stock in a transaction on Thursday, May 23rd. The shares were sold at an average price of $57.79, for a total value of $94,775.60. Following the sale, the director now directly owns 10,091 shares in the company, […]
Cytokinetics (NASDAQ:CYTK – Free Report) had its price target lowered by HC Wainwright from $94.00 to $90.00 in a report released on Thursday, Benzinga reports. The brokerage currently has a buy rating on the biopharmaceutical company’s stock. CYTK has been the topic of several other research reports. JMP Securities reduced their price target on shares […]
Cytokinetics (NASDAQ:CYTK – Free Report) had its price target lowered by Bank of America from $70.00 to $60.00 in a research report report published on Thursday, Benzinga reports. The firm currently has a neutral rating on the biopharmaceutical company’s stock. Other equities research analysts have also issued reports about the company. Barclays decreased their target […]
Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE – Free Report) – Research analysts at Wedbush upped their Q2 2024 earnings per share estimates for Monte Rosa Therapeutics in a note issued to investors on Tuesday, May 21st. Wedbush analyst R. Driscoll now forecasts that the company will post earnings of ($0.37) per share for the quarter, up […]